Refractory epilepsy: clinical overview (Q36742732)

16 August 2017

1 reference

title

Refractory epilepsy: clinical overview (English)

1 reference

16 August 2017

Jacqueline A French

1

0 references

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

48 Suppl 1

1 reference

16 August 2017

3-7

1 reference

Early identification of refractory epilepsy

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

How long does it take for partial epilepsy to become intractable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Is the underlying cause of epilepsy a major prognostic factor for recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Genetics of idiopathic generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Risk of recurrent seizures after two unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Response to first drug trial predicts outcome in childhood temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

21 January 2018

Complex febrile seizures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Revisiting the concept of identifiable neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00992.X

10.1111/J.1528-1167.2007.00992.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17316406